Pathogenesis of ascites and hepatorenal syndrome.

نویسندگان

  • S P Wilkinson
  • K P Moore
  • V Arroyo
چکیده

Ascites is one of the most common complications of cirrhosis and has a one year mortality of up to 50%. For fluid to accumulate in any clinical situation the amount of sodium ingested must exceed that excreted by the kidneys and the virtual absence of sodium from the urine of ascitic patients was first documented by Farnsworth and Krakusin in 1948.' Five years later Chart and Shipley showed such patients to have an excess of a sodium retaining hormone in their urine (later identified as aldosterone).2 Four decades after these discoveries the inter-relationship between renal function, hormonal changes and ascites formation remains controversial. At the other extreme of functional renal changes up to 85% ofpatients dying with cirrhosis have renal failure and, where there is no apparent cause other than the liver disease, is termed 'hepatorenal syndrome.' In 1863 Flint noted that proteinuria was uncommon and kidney morphology often normal, but some patients showed a variety of renal parenchymal changes.3 Hecker and Sherlock confirmed the absence of proteinuria and normal histology in many patients and reported very low urine sodium concentrations findings of a prerenal type of uraemia.

برای دانلود رایگان متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Hepatorenal syndrome in cirrhosis: pathogenesis and treatment.

Hepatorenal syndrome (HRS) is a major complication in cirrhosis, with an annual incidence in patients with ascites of approximately 8%.1 It develops at the latest phase of the disease and, although initially considered without impact in prognosis (patients would die with and not by the renal failure), there is now evidence that it is an important determinant in survival. There are more reviews ...

متن کامل

Treatment of hepatorenal syndrome

• Absence of parenchymal kidney disease as indicated by proteinuria >500 mg/day, micro-hematuria (>50 RBC/high power field) and/or abnormal renal ultrasound International Ascites Club, November 2005 • No current or recent treatment with nephrotoxic drugs • Absence of shock b.w per day up to a maximum of 100 g/day • Serum creatinine over 1.5 mg/dL (133 μmol/L) • Cirrhosis with ascites Table 1: D...

متن کامل

The natural history and management of hepatorenal disorders: from pre-ascites to hepatorenal syndrome.

In cirrhosis, the natural history of hepatorenal disorders starts with a pre-ascitic stage and is followed by the development of ascites; hepatorenal syndrome (HRS) begins with compensated renal sodium retention, or pre-ascites. In pre-ascites, the renal sodium retaining tendency leads to 'overfilling' of total blood volume, with increased glomerular filtration rates (GFR), overcoming the renal...

متن کامل

Patient selection and survival after peritoneovenous shunting for nonmalignant ascites.

Patient selection and survival after peritoneovenous shunting for nonmalignant ascites was assessed in 30 patients undergoing 44 peritoneovenous shunting procedures over a 5-year period. Indications for peritoneovenous shunting included refractory ascites alone, refractory ascites complicated by hepatorenal syndrome, and nonrefractory but recurrent ascites. Fifty-six percent of shunting procedu...

متن کامل

Hepatorenal Syndrome and Hyponatremia

• Hyponatremia and hepatorenal syndrome are complications that occur in patients with cirrhosis and ascites and represent a stage of “further” decompensation of cirrhosis • Worsened vasodilatation with consequent non-osmotic release of arginine-vasopressin and renal vasoconstriction are the main pathogenic mechanism for hyponatremia and hepatorenal syndrome, respectively • Both hyponatremia and...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

عنوان ژورنال:
  • Gut

دوره Suppl  شماره 

صفحات  -

تاریخ انتشار 1991